Eelko den Breejen
Pfizer (Global)
Eelko den Breejen is listed as Pfizer (Global). Eelko is scheduled to speak at ISPOR Europe 2026 on 11 November 2026.
Compiled from published conference agendas; not yet confirmed by Eelko. Is this you? Claim this profile.
About
Eelko is Global Access, Strategy & Pricing Oncology Team Lead and acts as the Global Head of Oncology Portfolio & Market Engagement at Pfizer. He joined Pfizer via the integration of Seagen where he served as the Head of International Market Access & Policy. Eelko has over 15 years industry experience in market access and policy functions with increasing responsibility at Global, Regional and Local level, e.g. previously he served as Head of Market Access and Corporate Affairs for Biogen in the Netherlands and has worked as the Global Policy Lead for Precision Oncology at Roche in Switzerland. Eelko holds a BSc in Physiotherapy, a MSc in Health Economics, Policy & Law and followed the Political Science program at the Netherlands Institute of Government.